Word

COVIDSEQ

Status

Registered

Status Code

700

Status Date

Tuesday, October 25, 2022

Serial Number

88983895

Registration Number

6885352

Registration Date

Tuesday, October 25, 2022

Mark Type

4000

Filing Date

Friday, April 24, 2020

Published for Opposition

Tuesday, June 8, 2021

Trademark Owner History

Illumina, Inc. - Original Registrant

Classifications

5 Diagnostic agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical use; Diagnostic reagents and preparations for medical use; Kits comprised principally of diagnostic reagents with a protocol for use thereof for medical purposes; Kits comprised of diagnostic nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, biological preparations for medical genetic testing and medical diagnostic purposes; diagnostic agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical use in the fields of medical diagnostics, clinical diagnostics, medical forensics, laboratory medicine, genetic testing, and genetics; all of the foregoing for the detection of or in the field of COVID-19

1 Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical or veterinary use; Kits comprised principally of reagents with a protocol for use thereof for non-medical purposes; Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, genetic testing, and genetics, not for medical or veterinary purposes; Kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, and biological preparations for scientific and research use including in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, genetic testing, and genetics, not for medical or veterinary purposes; all of the foregoing for the detection of or in the field of COVID-19

Trademark Events

Oct 25, 2022

Notice Of Registration Confirmation Emailed

Oct 25, 2022

Registered-Principal Register

Sep 20, 2022

Notice Of Acceptance Of Statement Of Use E-Mailed

Sep 19, 2022

Allowed Principal Register - Sou Accepted

Sep 19, 2022

Teas/Email Correspondence Entered

Sep 19, 2022

Correspondence Received In Law Office

Sep 19, 2022

Assigned To Lie

Sep 7, 2022

Teas Response To Office Action Received

Jul 20, 2022

Teas Extension Received

Mar 8, 2022

Notification Of Non-Final Action E-Mailed

Mar 8, 2022

Non-Final Action E-Mailed

Mar 8, 2022

Su - Non-Final Action - Written

Mar 3, 2022

Statement Of Use Processing Complete

Feb 16, 2022

Use Amendment Filed

Mar 3, 2022

Divisional Processing Complete

Feb 16, 2022

Divisional Request Received

Mar 3, 2022

Case Assigned To Intent To Use Paralegal

Feb 16, 2022

Teas Request To Divide Received

Feb 16, 2022

Teas Statement Of Use Received

Feb 3, 2022

Notice Of Approval Of Extension Request E-Mailed

Feb 1, 2022

Sou Extension 1 Granted

Feb 1, 2022

Sou Extension 1 Filed

Feb 1, 2022

Teas Extension Received

Aug 3, 2021

Noa E-Mailed - Sou Required From Applicant

Jun 8, 2021

Official Gazette Publication Confirmation E-Mailed

Jun 8, 2021

Published For Opposition

May 19, 2021

Notification Of Notice Of Publication E-Mailed

May 3, 2021

Approved For Pub - Principal Register

Apr 30, 2021

Examiner's Amendment Entered

Apr 30, 2021

Notification Of Examiners Amendment E-Mailed

Apr 30, 2021

Examiners Amendment E-Mailed

Apr 30, 2021

Examiners Amendment -Written

Apr 22, 2021

Teas/Email Correspondence Entered

Apr 21, 2021

Correspondence Received In Law Office

Apr 21, 2021

Teas Response To Office Action Received

Oct 21, 2020

Notification Of Non-Final Action E-Mailed

Oct 21, 2020

Non-Final Action E-Mailed

Oct 21, 2020

Non-Final Action Written

Oct 19, 2020

Assigned To Examiner

Jul 9, 2020

Preliminary/Voluntary Amendment - Entered

Jul 8, 2020

Assigned To Lie

Jun 25, 2020

Teas Voluntary Amendment Received

May 6, 2020

New Application Office Supplied Data Entered In Tram

Apr 28, 2020

New Application Entered In Tram